Internal Medicine, Endocrinology, Diabetes, & Metabolism · Coral Gables, FL
NPI
1689659096
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2695 S Le Jeune Rd, Suite 203
Coral Gables, FL, 33134
Phone (305) 672-8559
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
947 services
Medicare patients, 2024
238
Average age 72
Drug cost, 2024
$3.1M
9,401 prescriptions
Company payments, 2025
$110K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Misha Denham was code 99214 (office e&m - established), 371 times for 206 patients. In total Misha Denham billed 947 services in 18 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 371 | 206 | $94.00 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 130 | 111 | $13.46 | $1,750 |
| 95251 Test - Miscellaneous | Office | 117 | 49 | $26.86 | $3,143 |
| 99443 Telephone Services | Office | 79 | 50 | $101.71 | $8,035 |
| 82962 Clinical Chemistry | Office | 46 | 36 | $3.21 | $148 |
| 96372 Injection Administration | Office | 46 | 37 | $10.74 | $494 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 42 | 35 | $0.92 | $38.56 |
| 99215 Office E&M - Established | Office | 36 | 28 | $131.16 | $4,722 |
| 76536 Ultrasound - Nonspecific | Office | 36 | 34 | $81.14 | $2,921 |
| 95250 Test - Miscellaneous | Office | 12 | 11 | $113.04 | $1,357 |
By year: 2022 $53K for 840 services; 2023 $55K for 893 services; 2024 $60K for 947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 46 | 36 | $3.21 | $148 |
Medicare prescription drug claims, 2024
In 2024, the drug Misha Denham prescribed most often to Medicare patients was Levothyroxine Sodium, with 629 prescriptions and refills. In total Misha Denham wrote 9,401 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 629 | 1,716 | 167 | $7,133 |
| Metformin Hcl Generic | 300 | 851 | 94 | $2,327 |
| Mounjaro Tirzepatide | 287 | 389 | 60 | $412K |
| Atorvastatin Calcium Generic | 284 | 766 | 95 | $2,496 |
| Ozempic Semaglutide | 260 | 442 | 60 | $424K |
| Synthroid Levothyroxine Sodium | 259 | 737 | 67 | $29K |
| Liothyronine Sodium Generic | 245 | 670 | 76 | $13K |
| Rosuvastatin Calcium Generic | 244 | 703 | 84 | $2,691 |
| Losartan Potassium Generic | 228 | 639 | 79 | $2,010 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 224 | 610 | 84 | $7,648 |
| Tresiba Flextouch U-100 Insulin Degludec | 197 | 493 | 70 | $183K |
| Jardiance Empagliflozin | 197 | 414 | 48 | $245K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 172 | 423 | 80 | $2,003 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 171 | 382 | 74 | $24K |
| Lisinopril Generic | 158 | 459 | 51 | $1,303 |
Brand drugs: 3,021 claims; generic drugs: 5,747 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Misha Denham $110K ($110K in general payments such as food, travel and fees) from 26 companies. The largest payer was Lilly USA, LLC with $83K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 137 | $83K |
| Novo Nordisk Inc NVO | 32 | $18K |
| Verity Pharmaceuticals Inc. | 7 | $7,810 |
| Mannkind Corporation MNKD | 4 | $178 |
| Xeris Pharmaceuticals, Inc. | 4 | $79.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64.05 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $63.52 |
| Antares Pharma, Inc. | 3 | $58.74 |
| Abbvie Inc. ABBV | 2 | $51.84 |
| Corcept Therapeutics CORT | 2 | $40.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.